High-performance liquid chromatography of etoposide in plasma and urine
- 31 December 1985
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 339 (2), 419-423
- https://doi.org/10.1016/s0378-4347(00)84674-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Automated liquid chromatographic analysis of the anti-tumorigenic drugs etoposide (VP 16-213) and teniposide (VM 26)Journal of Chromatography B: Biomedical Sciences and Applications, 1983
- Etoposide salvage therapy for refractory germ cell tumors: an updateCancer Treatment Reviews, 1982
- Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancerCancer Chemotherapy and Pharmacology, 1982
- VP16-213 (Etoposide)Cancer Chemotherapy and Pharmacology, 1982
- Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- High-performance liquid chromatography determination of 4′-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene β-d-glucopyranoside) (VP 16-213) in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Analysis of 4′-demethylepipodophyllotoxin-9-(4,6-o-ethylidene-β-d-glucopyranoside) by high-pressure liquid chromatographyJournal of Pharmaceutical Sciences, 1980
- Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Small-cell lung cancer: A curable disease?Respiratory Medicine, 1979
- Etoposide (VP-16-213)Cancer Treatment Reviews, 1979